Drug Database
Back to search

Italy· 050666027

OPZELURA*crema derm 1 tubo 100 g 15 mg/g

A ruxolitinib product containing ruxolitinib, registered in Italy by INCYTE BIOSCIENCES DISTRIB BV, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC D11AH09

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · ITPublic registernormalisedOPZELURA*crema derm 1 tubo 100 g 15 m…ATCD11AH09REGISTER NO.050666027PACKS LISTED1CHECKEDJune 4, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ruxolitinibAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ruxolitinib is registered in 14 of 19 countries.

Countries holding a registration under ATC D11AH09 (ruxolitinib), each read from that country’s own register.

  • This record: Italy
  • 9 of them publish a price we can compare per daily dose
Search ruxolitinib products by name

Ruxolitinib · ATC D11AH09

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Active substance
Ruxolitinib
Manufacturer
INCYTE BIOSCIENCES DISTRIB BV
Country
Italy (IT)
ATC code
D11AH09
ATC class
Ruxolitinib
Defined daily dose
30 mg, T
Reimbursed
Yes
Last checked
June 4, 2026

Packs & prices · 1

1 priced
  • aic
    050666027
    OPZELURA*crema derm 1 tubo 100 g 15 mg/g
    EUR 1117.11

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ruxolitinib in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ruxolitinib products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Austria · Polink, Ruxib
  • Bulgaria · Руджави, Руксолитиниб Сандоз
  • Cyprus · Ruxolitinib Sandoz
  • Czechia · Ruxolitinib Msn, Ruxolitinib Sandoz
  • Denmark · Ruxolitinib "sandoz", Ruxolitinib Devatis
  • Estonia · Ruxolitinib Msn
  • Spain · Ruxolitinib Cipla, Ruxolitinib Vivanta
  • Finland · Ruxolitinib Orion
  • France · Ruxolitinib Biogaran, Ruxolitinib Olpha
  • United Kingdom (Northern Ireland) · Ruxolitinib Msn Laboratories Europe, Ruxolitinib Torrent
  • Greece · Jakulya
  • Croatia · Ruksolitinib Devatis, Ruksolitinib Msn
  • Hungary · Ruxolitinib Sandoz
  • Iceland · Jakavi, Jakulya
  • Liechtenstein · Jakavi, Opzelura
  • Lithuania · Ruxolitinib Msn, Ruxolitinib Olpha
  • Latvia · Ruxolitinib Msn
  • Malta · Donlize, Ruxolitinib Medichem
  • Netherlands · Ruxolitinib Accord, Ruxolitinib Advanz Pharma
  • Norway · Jakavi, Opzelura
  • Romania · Ruxolitinib Msn
  • Sweden · Ruxolitinib Devatis, Ruxolitinib Orion

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6b1ceee3-4585-4ec5-8987-f3edcc4264ce
GET /v1/drugs/6b1ceee3-4585-4ec5-8987-f3edcc4264ce?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "price": 1117.11,
  "source": "aifa",
  "currency": "EUR",
  "strength": "RUXOLITINIB 100G 15MG/G CREMA USO CUTANEO",
  "substance": "Ruxolitinib",
  "equivalence_group": "MYY",
  "transparency_flag": null
}
API referenceMCP serverPlans

See everything about ruxolitinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console